BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 22504904)

  • 1. Celecoxib induces apoptosis and cell-cycle arrest in nasopharyngeal carcinoma cell lines via inhibition of STAT3 phosphorylation.
    Liu DB; Hu GY; Long GX; Qiu H; Mei Q; Hu GQ
    Acta Pharmacol Sin; 2012 May; 33(5):682-90. PubMed ID: 22504904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anticancer effects of celecoxib through inhibiton of STAT3 phosphorylation and AKT phosphorylation in nasopharyngeal carcinoma cell lines.
    Liu DB; Long GX; Mei Q; Wang JF; Hu GY; Gan L; Li WW; Sun W; Liu SF; Jiang JZ; Hu GQ
    Pharmazie; 2014 May; 69(5):358-61. PubMed ID: 24855827
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stat3 inhibitor Stattic exhibits potent antitumor activity and induces chemo- and radio-sensitivity in nasopharyngeal carcinoma.
    Pan Y; Zhou F; Zhang R; Claret FX
    PLoS One; 2013; 8(1):e54565. PubMed ID: 23382914
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Celecoxib enhances radiosensitivity via induction of G₂-M phase arrest and apoptosis in nasopharyngeal carcinoma.
    Zhang SX; Qiu QH; Chen WB; Liang CH; Huang B
    Cell Physiol Biochem; 2014; 33(5):1484-97. PubMed ID: 24854838
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oleanane triterpenoid CDDO-Me induces apoptosis in multidrug resistant osteosarcoma cells through inhibition of Stat3 pathway.
    Ryu K; Susa M; Choy E; Yang C; Hornicek FJ; Mankin HJ; Duan Z
    BMC Cancer; 2010 May; 10():187. PubMed ID: 20459702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LPLUNC1 suppresses IL-6-induced nasopharyngeal carcinoma cell proliferation via inhibiting the Stat3 activation.
    Liao Q; Zeng Z; Guo X; Li X; Wei F; Zhang W; Li X; Chen P; Liang F; Xiang B; Ma J; Wu M; Tang H; Deng M; Zeng X; Tang K; Xiong W; Li G
    Oncogene; 2014 Apr; 33(16):2098-109. PubMed ID: 23708661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of cyclooxygenase 2 inhibitors on biological traits of nasopharyngeal carcinoma cells.
    Chen PY; Long QC
    Acta Pharmacol Sin; 2004 Jul; 25(7):943-9. PubMed ID: 15210070
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Celecoxib induces dose dependent growth inhibition in nasopharyngeal carcinoma cell lines independent of cyclooxygenase-2 expression.
    Chan CM; Ma BB; Wong SC; Chan AT
    Biomed Pharmacother; 2005 Oct; 59 Suppl 2():S268-71. PubMed ID: 16507390
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sequential treatment of HPV E6 and E7-expressing TC-1 cells with bortezomib and celecoxib promotes apoptosis through p-p38 MAPK-mediated downregulation of cyclin D1 and CDK2.
    Kim JE; Lee JI; Jin DH; Lee WJ; Park GB; Kim S; Kim YS; Wu TC; Hur DY; Kim D
    Oncol Rep; 2014 May; 31(5):2429-37. PubMed ID: 24627094
    [TBL] [Abstract][Full Text] [Related]  

  • 10. EBV-LMP1-targeted DNAzyme induces DNA damage and causes cell cycle arrest in LMP1-positive nasopharyngeal carcinoma cells.
    Ma X; Xu Z; Yang L; Xiao L; Tang M; Lu J; Xu S; Tang Y; Wen X; Deng X; Sun L; Cao Y
    Int J Oncol; 2013 Nov; 43(5):1541-8. PubMed ID: 24042231
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of a JAK inhibitor, AG490, on proliferation and apoptosis of human nasopharyngeal carcinoma cell line CNE-2Z.
    Wu MH; Chen XY; Cai KR
    Ai Zheng; 2009 Jan; 28(1):24-8. PubMed ID: 19448411
    [TBL] [Abstract][Full Text] [Related]  

  • 12. COX-2-independent induction of apoptosis by celecoxib and polyamine naphthalimide conjugate mediated by polyamine depression in colorectal cancer cell lines.
    Xie SQ; Zhang YH; Li Q; Wang JH; Li JH; Zhao J; Wang CJ
    Int J Colorectal Dis; 2012 Jul; 27(7):861-8. PubMed ID: 22159752
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective cyclooxygenase-2 inhibitors inhibit growth and induce apoptosis of bladder cancer.
    Gee J; Lee IL; Jendiroba D; Fischer SM; Grossman HB; Sabichi AL
    Oncol Rep; 2006 Feb; 15(2):471-7. PubMed ID: 16391871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ABT-199-mediated inhibition of Bcl-2 as a potential therapeutic strategy for nasopharyngeal carcinoma.
    Wang Y; Wang Y; Fan X; Song J; Wu H; Han J; Lu L; Weng X; Nie G
    Biochem Biophys Res Commun; 2018 Sep; 503(3):1214-1220. PubMed ID: 30017199
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of COX-2 inhibitor celecoxib on proliferation, apoptosis of HL-60 cells and its mechanism].
    Xie X; Li J; Wang RC; Geng RL; Wang SY; Wang C; Zhao XY; Hao HL
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Jun; 22(3):707-11. PubMed ID: 24989281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Scoparone exerts anti-tumor activity against DU145 prostate cancer cells via inhibition of STAT3 activity.
    Kim JK; Kim JY; Kim HJ; Park KG; Harris RA; Cho WJ; Lee JT; Lee IK
    PLoS One; 2013; 8(11):e80391. PubMed ID: 24260381
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Correlation of Epstein-Barr virus-encoded latent membrane protein 1 (LMP1) to fascin and phosphorylated Stat3 in nasopharyngeal carcinoma].
    Liu QY; Han AJ; You SY; Dong Y; Yang QX; Wu JH; Li MF
    Ai Zheng; 2008 Oct; 27(10):1070-6. PubMed ID: 18851787
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genistein induced anticancer effects on pancreatic cancer cell lines involves mitochondrial apoptosis, G
    Bi YL; Min M; Shen W; Liu Y
    Phytomedicine; 2018 Jan; 39():10-16. PubMed ID: 29433670
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppression of N-methyl-N-nitrosourea/testosterone-induced rat prostate cancer growth by celecoxib: effects on cyclooxygenase-2, cell cycle regulation, and apoptosis mechanism(s).
    Narayanan BA; Condon MS; Bosland MC; Narayanan NK; Reddy BS
    Clin Cancer Res; 2003 Aug; 9(9):3503-13. PubMed ID: 12960143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Berberine suppresses tumorigenicity and growth of nasopharyngeal carcinoma cells by inhibiting STAT3 activation induced by tumor associated fibroblasts.
    Tsang CM; Cheung YC; Lui VW; Yip YL; Zhang G; Lin VW; Cheung KC; Feng Y; Tsao SW
    BMC Cancer; 2013 Dec; 13():619. PubMed ID: 24380387
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.